Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

NCT07638800 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Trial Participants

Interventions

DRUG: GenSci155 Injection
DRUG: Placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.